Prednisolone in the treatment of adrenal insufficiency: A re-evaluation of relative potency

Journal of Pediatrics

Volumn 143, Issue 3, 2003, Pages 402-405

  Punthakee, Zubin ^a   Legault, Laurent ^a   Polychronakos, Constantin ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; HYDROXYPROGESTERONE; PREDNISOLONE;

ADRENAL INSUFFICIENCY; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG POTENCY; DRUG WITHDRAWAL; EVALUATION; FEMALE; GROWTH INHIBITION; GROWTH RATE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STEROID THERAPY;

EID: 0141727719     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00294-4     Document Type: Article

References (19)

1. Styne DM, Richards GE, Bell JJ, Conte FA, Morishirna A, Kaplan SL, et al. Growth patterns in congenital adrenal hyperplasia: correlation of glucocorticoid therapy with stature. In: Lee PA, Plotnick LP, Kowarski AA, Midgeon CJ, editors. Congenital adrenal hyperplasia. Baltimore: University, Park Press; 1977. p. 247-261.
2. Falliers CJ, Tan LS, Szentivanyi J, Jorgensen JR, Bukantz S. Childhood asthma and steroid therapy has influences on growth. Am J Dis Child 1963;105:41-51.
3. Van Metre TE, Niermann WA, Rosen LJ. A comparison of the growth suppressive effect of cortisone, prednisone, and other adrenal cortical hormones. J Allergy 1960;31:531-42.
4. Hansen JW, Loriaux LL. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia. Pediatrics 1976;57:942-7.
5. Van Der Veer ALJ, Moonelaar AJ. Some aspects of steroid therapy in congenital adrenal hyperplasia [abstract]. J Endocrinol 1970;48:lxxvii.
6. Ortega E, Rodriguez C, Strand LJ, Segre E. Effects of cloprednol and other corticosteroids on hypothalamic-pituitary-adrenal axis function. J Int Med Res 1976;4:326-37.
7. Hedner LP. Quantitative assay of the acute hypothalamo-pitultary depressing effect of corticosteroids in man. J Endocrinol 1967;37:57-62.
8. Meilke AW, Tyler FH. Potency and duration of action of glucocorticoids: effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1977;63:200-7.
9. Slater JDH, Heffron PF, Vernet A, Nabarro JDN. Clinical and metabolic effects of dexatuethasone. Lancet 1959;1:173-7.
10. Boland EW. Hydrocortisone (Kendall's Compound F): experiences with the free and acetate forms in rheumatoid arthritis. J Am Pharm Assoc 1952;13:540.
11. Ringler I, West K, Dulin WE, Boland EW. Biological potencies of chemically modified adrenocorticosteroids in rat and man. Metabolism 1964;13:37-44.
12. Liddle GW. Studies of structure-function relationships of steroids II the 6α-methylcorticosteroids. Metabolism 1958;7:405-15.
13. Imbimbo B, Milani S. Potency ratio, clinical equivalence, and wasting ratio estimate of different glucocorticoids. Calcif Tiss Int 1991;49:367-8.
14. Miller WL. The adrenal cortex. In: Rudolph AM, Hoffman JIE, editors. Pediatrics. Norwalk: Appleton & Lange; 1991. p. 1584-613.
15. Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985;107:317-29.
16. Guo S, Roche AF, Fomon SJ, Nelson SE, Chumlea WC, Rogers RR, et al. Reference data on gains in weight and length during the first two years of life. J Pediatr 1991;119:355-62.
17. National Health and Nutrition Examination Survey: Clinical Growth Charts (21 November 2000). Retrieved 30 August 2001 from the website for the Centre for Disease Control and Prevention - National Centre for Health Statistics: http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/clinical_charts.htm.
18. Simon JL, Bruce P. Resampling: a tool for everyday statistical work. Chance 1991;4:22-32.
19. Speiser PW. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Endocrinol Metab Clin N Am 2001;30:31-59.